Back to Search
Start Over
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer.
- Source :
- Journal of Medicinal Chemistry; 10/26/2023, Vol. 66 Issue 20, p14150-14174, 25p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00222623
- Volume :
- 66
- Issue :
- 20
- Database :
- Supplemental Index
- Journal :
- Journal of Medicinal Chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 173311387
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.3c01242